Controlled Substitution of Soy Protein for Meat Protein: Effects on Calcium Retention, Bone, and Cardiovascular Health Indices in Postmenopausal Women

University of Arkansas at Little Rock, Little Rock, Arkansas, United States
Journal of Clinical Endocrinology &amp Metabolism (Impact Factor: 6.21). 02/2005; 90(1):181-9. DOI: 10.1210/jc.2004-0393
Source: PubMed


In a controlled feeding study, the effects of substituting 25 g soy protein for meat on calcium retention and bone biomarkers were determined. Postmenopausal women (n = 13) ate two diets that were similar, except that, in one diet, 25 g high-isoflavone soy protein (SOY) was substituted for an equivalent amount of meat protein (control diet), for 7 wk each in a randomized crossover design. After 3 wk of equilibration, calcium retention was measured by labeling the 2-d menu with (47)Ca, followed by whole-body counting for 28 d. Urinary calcium and renal acid excretion were measured at wk 3, 5, and 7. Biomarkers of bone and cardiovascular health were measured at the beginning and end of each diet. Calcium was similarly retained during the control and SOY diets (d 28, percent dose, mean +/- pooled sd: 14.1 and 14.0 +/- 1.6, respectively). Despite a 15-20% lower renal acid excretion during the SOY diet, urinary calcium loss was unaffected by diet. Diet also did not affect any of the indicators of bone or cardiovascular health. Substitution of 25 g high isoflavone soy protein for meat, in the presence of typical calcium intakes, did not improve or impair calcium retention or indicators of bone and cardiovascular health in postmenopausal women.

Download full-text


Available from: Janet R Hunt, Dec 23, 2014
  • Source
    • "). This hypothesis would also account for the lack of effect observed with 54 mg genistein supplementation (D'Anna et al., 2005), 50 mg of isoflavones isolated from soy (Reimann et al., 2006) and substitution of 25 g soy protein for meat protein (Roughead et al., 2005) as these studies did not include a soy vs milk protein comparison. Finally, the plasma lipid concentrations of subjects may explain variability in Hcy response to soy consumption; soy may be more likely to influence Hcy in subjects with elevated low-density lipoprotein cholesterol (LDL-C) concentrations . "
    [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the effect of soy protein containing isoflavones on homocysteine (Hcy), C-reactive protein (CRP), soluble E-selectin (sE-selectin), soluble vascular adhesion molecule-1 (sVCAM-1) and soluble intercellular adhesion molecule-1 (sICAM-1). In a randomized crossover design, 34 postmenopausal women consumed soy protein isolate (26+/-5 g protein containing 44+/-8 mg isoflavones per day) or milk protein isolate (26+/-5 g protein per day) for 6 weeks each. Fasting blood samples were collected at the end of each diet period and end points analyzed by enzyme-linked immunosorbent assay. Concentrations of Hcy, CRP, sE-selectin, sVCAM-1 and sICAM-1 were not different between soy and milk diet treatments. Results did not differ by equol production status or by baseline lipid concentration. Adjustment for intake of folate and methionine did not alter the Hcy results. These data suggest that decreasing vascular inflammation and Hcy concentration are not likely mechanisms by which soy consumption reduces coronary heart disease risk.
    European Journal of Clinical Nutrition 10/2007; 62(12):1419-25. DOI:10.1038/sj.ejcn.1602885 · 2.71 Impact Factor
  • Source
    Article: Menopause
    [Show abstract] [Hide abstract]
    ABSTRACT: Avis NE, Crawford S, Johannes CB. Menopause. In: Handbook of Women’s Sexual and Reproductive Health, eds. GM Wingood and RJ DiClemente. New York: Kluwer Academic/Plenum Publishers, 2002, pp. 367-391. ISBN 0306466511, 9780306466519. Limited preview available via Google Book Search.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Moderate weight loss not only reduces the comorbidities associated with obesity, but has also been shown to reduce bone mass. Supplementation with specific nutrients, such as calcium, may attenuate loss of bone mass during weight reduction. Recently, high-protein (HP) weight-loss diets have been shown to be as effective as, or sometimes more effective than, standard high carbohydrate weight loss diets in reducing symptoms associated with metabolic syndrome. The effect of higher protein diets on bone is important due to the greater acceptance among health care providers. Dietary protein has also been shown to have specific effects on the regulation of bone health. Some large epidemiological studies have shown a beneficial impact of protein on bone health, which is supported by intervention studies in patients with osteoporosis. In contrast, others have suggested that a HP diet is associated with low bone mineral density (BMD) and greater fracture risk and have attributed this to a greater acid load and increased urinary calcium excretion. Since lower calcium intake may mediate the negative effect of HP diets on bone, controlled trials to study the effects of protein are important. During weight reduction, there is both reduced calcium absorption and serum insulin-like growth factor-1 (IGF-1), which may contribute to bone loss, yet may be positively influenced by additional protein in the diet. The role of dietary protein during caloric restriction on bone health and potential mechanisms mediating these effects is reviewed.
    Nutritional Influences on Bone health, Edited by Peter Burckhardt, Bess Dawson-Hughes, Connie M. Weaver, 01/1970: pages 27-33; Springer.
Show more